Klikedi (Diclofenac Sodium)

Diclofenac sodium inhibits cyclooxygenase enzymes (COX‑1 and COX‑2) in peripheral tissues, which lowers prostaglandin production. This reduction diminishes the inflammatory response and provides localized analgesic effects at the site where the gel is applied.

The appropriate amount of Klikedi to apply is determined by the prescribing healthcare professional based on the specific condition, severity, and patient characteristics. Patients should follow the prescriber’s instructions and not exceed the recommended application frequency.

Safety data for topical diclofenac in pregnancy are limited, and use is generally avoided in the third trimester. Caution is advised during breastfeeding because diclofenac can be excreted in breast milk. Consultation with a healthcare provider is essential before use.

To request Klikedi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Klikedi delivers diclofenac directly to the skin, offering targeted pain relief with lower systemic exposure compared with oral NSAIDs. This can reduce the risk of gastrointestinal and cardiovascular side effects, making it a preferred option for patients needing localized therapy.

Klikedi should be stored at room temperature, preferably below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and extreme temperatures to maintain its stability and efficacy.

Klikedi is applied topically to clean, dry skin over the affected area. The prescribed amount is spread in a thin layer and gently massaged until absorbed. Hands should be washed after application, and the treated area should not be covered with occlusive dressings unless directed by a clinician.

Serious risks include severe allergic reactions such as angioedema, rare but life‑threatening skin conditions like Stevens‑Johnson syndrome, and systemic NSAID effects including gastrointestinal bleeding, renal impairment, and cardiovascular events, especially with extensive use or in high‑risk patients.

Klikedi should not be used by individuals with known hypersensitivity to diclofenac or any component of the formulation, by patients with active skin infections or open wounds at the application site, and by those in the third trimester of pregnancy. Consultation with a healthcare professional is required for other contraindications.